Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis

Clinical trial NCT05011305 · COMPLETED

Trial details

NCT number: NCT05011305
Sponsor: Zydus Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis Fibrosis

Start date: 2021-08-18
Primary completion: 2025-09-12
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.